CB1 agonist 1

• Description :

  CB1 agonist 1 (compound 22) is an agonist of CB1. CB1 agonist 1 shows affinity to CB1 receptor with an pIC50 value of 5.7. CB1 agonist 1 can be used for the research of brain disorders[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319

• Target :

  Cannabinoid Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/cb1-agonist-1.html

• Purity :

  99.84

• Solubility :

  DMSO : 250 mg/mL (ultrasonic)

• Smiles :

  O=C(C1=C(OC2=CC=CC=C2)C=CC=C1)NC3=CC=C(C)C(S(=O)(N4CCOCC4)=O)=C3

• Molecular Formula :

  C24H24N2O5S

• Molecular Weight :

  452.52

• Precautions :

  H302, H315, H319

• References & Citations :

  [1]Lambeng N, et al. Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: identification of a lead and initial SAR studies. Bioorg Med Chem Lett. 2007 Jan 1;17 (1) :272-7.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [851212-80-1]